Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
07/13/2005 | EP1551418A1 Substituted ketophosphonate compounds having bone anabolic activity |
07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
07/13/2005 | CN1639344A A method of selectively producing male or female sterile plants |
07/13/2005 | CN1639177A Novel phosoxophite ligands and use thereof in carbonylation processes |
07/13/2005 | CN1639176A Phosphonites, use thereof as ligand in transition metal complexes and method for production of nitriles |
07/13/2005 | CN1639175A Novel phosphonamides, process for producing the same, and use thereof |
07/13/2005 | CN1639174A Oligomeric, hydroxy-terminated phosphonates |
07/13/2005 | CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
07/13/2005 | CN1639110A Haloacetamide and azide substituted compounds and methods of use thereof |
07/13/2005 | CN1638168A Quadribasic phthalocyanine copper film with controllably doped tetrachlorobenzoquinone/triphenyl phosphorus and its prepn process |
07/13/2005 | CN1637008A High metathesis activity ruthenium and osmium metal carbene complexes |
07/13/2005 | CN1636971A Oxime derivatives and the use thereof as latent acids |
07/13/2005 | CN1210284C Bisphenol-A bis (diphenyl phosphate)-based flame retardant |
07/13/2005 | CN1210283C Process for making glyphosate by oxidizing N-substituted glyphosates |
07/13/2005 | CN1210280C Integrated process for preparation of diene complexes |
07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
07/13/2005 | CN1209964C Pesticide formulations containing phosphate ester surfactant and alkoxylated lignosulfonate |
07/12/2005 | US6916944 Bismuth compound, process of producing the same, and process of producing a film |
07/12/2005 | US6916937 For ishcemia/stroke therapy; calcium-activated potassium channel modulators |
07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
07/12/2005 | US6916460 Macrocyclic chelants for metallopharmaceuticals |
07/07/2005 | WO2005061501A2 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds |
07/07/2005 | WO2005061416A1 Method for isolating acids from chemical reaction mixtures by using 1-alkylimidazoles |
07/07/2005 | WO2005060647A2 Prodrugs of selective androgen receptor modulators and methods of use thereof |
07/07/2005 | WO2005060500A2 Process for manufacture of pentaerythritol diphosphites |
07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
07/07/2005 | WO2005007603A3 Fluorocombretastatin and derivatives thereof |
07/07/2005 | WO2005005447A3 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
07/07/2005 | US20050150013 Generating sex specific sterility in plants via vector transformation and expression of phytotoxic converting enzymes; hybrid seed production and enhanced crop yields |
07/07/2005 | US20050149164 Method for treating neurovascular aneurysms |
07/07/2005 | US20050148675 Efficient and inexpensive method to prepare ubiquinone precursors using benzenoid precursor with retention of the double bond stereochemistry; industrial scale; carbolumination of alkynes |
07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
07/07/2005 | US20050148623 HIV protease inhibiting compounds |
07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
07/07/2005 | US20050148531 Antisense agents; blocking agents (biotin); high throughput screening |
07/07/2005 | US20050148517 Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
07/07/2005 | US20050148042 Hybrid phosphoinositide phospholipids: compositions and uses |
07/07/2005 | US20050148032 Chemoselective ligation |
07/07/2005 | US20050147843 carbazole phenylpyridine metal complexes or conjugated with additional polymers, for use in a light-emitting device; light emission from triplet excited state |
07/07/2005 | DE10356822A1 Verfahren zur Abtrennung von Pb und Ni aus Co-haltigen Gemischen Process for the separation of Pb and Ni of Co-containing mixtures |
07/07/2005 | CA2548088A1 Process for manufacture of pentaerythritol diphosphites |
07/07/2005 | CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds |
07/07/2005 | CA2522874A1 Prodrugs of selective androgen receptor modulators and methods of use thereof |
07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
07/06/2005 | EP1549387A1 Antisense modulation of farnesoid x receptor expression |
07/06/2005 | EP1549322A2 Lipid a and other carbohydrate ligand analogs |
07/06/2005 | EP1060264B1 Dideoxy dye terminators |
07/06/2005 | CN1636004A Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
07/06/2005 | CN1635994A Process for preparation of carotenoids |
07/06/2005 | CN1634943A Acyclic nucleotide analogs, method for synthesis and antiviral application |
07/06/2005 | CN1634942A Stabilized silver sulfonate complex of organo-phosphine, method for synthesizing and use thereof |
07/06/2005 | CN1634941A Process for one-pot preparation of chloromethyl monosodium phosphonate |
07/06/2005 | CN1634940A Mixed bed ion exchange resin method for purifying lecithin and cephalin |
07/06/2005 | CN1634939A Supercritical CO2 extraction process for soya bean lecithin |
07/06/2005 | CN1634938A Process for preparing alkyl phosphate |
07/05/2005 | US6914161 Process to prepare a multidentate phosphine compound |
07/05/2005 | US6914148 Monomer for use in huaman therapeutics and diagnostics |
07/05/2005 | US6914056 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
07/05/2005 | US6913897 Comprises dioxetane compound and phosphatases |
07/05/2005 | CA2253545C Phosphatidic acid-comprising compositions |
07/05/2005 | CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
07/05/2005 | CA2093946C Methanediphosphonic acid formulations with ion exchangers |
06/30/2005 | WO2005058926A1 New process for preparing diisopropyl ((1-((2-amino-6-chloro-9h-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonate |
06/30/2005 | WO2005058925A1 New process for preparing diisopropyl ((1-((2-amino-6-halo-9h-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonate |
06/30/2005 | WO2005058924A1 Method for producing phosphonium salts |
06/30/2005 | WO2005058923A1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors |
06/30/2005 | WO2005058917A2 New oxazoline ligands for asymmetric catalysis |
06/30/2005 | WO2005058916A2 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins |
06/30/2005 | WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics |
06/30/2005 | WO2005058886A1 Novel oxazolidinone derivatives |
06/30/2005 | WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use |
06/30/2005 | WO2005058805A1 Process for producing optically active amine compound |
06/30/2005 | WO2005058789A2 Copper (i) formate complexes |
06/30/2005 | WO2005058788A1 Process of preparing glycolaldehyde |
06/30/2005 | WO2005058330A1 Phosphorus containing compounds useful for the regulation of ldl and lp(a) levels |
06/30/2005 | WO2005058250A2 Methods of administering water-soluble prodrugs of propofol for extended sedation |
06/30/2005 | WO2005040357A3 Compounds and methods for fluorescent labeling |
06/30/2005 | WO2005040178A9 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex |
06/30/2005 | WO2004100960A8 Anti-inflammatory phosphonate compounds |
06/30/2005 | WO2004096236A3 Immunomodulator phosphonate conjugates |
06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
06/30/2005 | US20050143475 Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
06/30/2005 | US20050143455 such as (4-methyl-trans-cyclohexane-1,2-diamine)-oxalatoplatinum |
06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
06/30/2005 | US20050143418 Pesticidal heterocycles |
06/30/2005 | US20050143349 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels |
06/30/2005 | US20050142542 Absobers materials used for removal or reduction of microbiocides from body fluids such as blood; filtration |
06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
06/30/2005 | US20050139822 A series of aromatic rings carrying a linear alkylene chain substituted with a polar group, e.g., 5-ethyl-5'''-(10-undecenyl)-2,2':5',2'':5'',2'''-quaterthiophene; thin films having the function of a dielectric layer and of a semiconductive layer; a self-assembled molecule (SAMS); low surface voltage |
06/30/2005 | CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use |
06/30/2005 | CA2549456A1 Process of preparing glycolaldehyde |
06/30/2005 | CA2548216A1 Methods of administering water-soluble prodrugs of propofol for extended sedation |
06/30/2005 | CA2546903A1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors |
06/30/2005 | CA2546480A1 Method for producing phosphonium salts |
06/29/2005 | EP1548021A1 One-part self-etching, self-priming dental adhesive composition |
06/29/2005 | EP1547603A2 Compositions and methods for use in targeting vascular destruction |
06/29/2005 | EP1546164A1 (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof |
06/29/2005 | EP1546163A1 Method for the production of acylphosphine oxides |
06/29/2005 | EP1546162A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |